TW256773B - - Google Patents

Info

Publication number
TW256773B
TW256773B TW083102373A TW83102373A TW256773B TW 256773 B TW256773 B TW 256773B TW 083102373 A TW083102373 A TW 083102373A TW 83102373 A TW83102373 A TW 83102373A TW 256773 B TW256773 B TW 256773B
Authority
TW
Taiwan
Application number
TW083102373A
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of TW256773B publication Critical patent/TW256773B/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW083102373A 1993-03-19 1994-03-18 TW256773B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939305693A GB9305693D0 (en) 1993-03-19 1993-03-19 Therapeutic triazine compounds and use

Publications (1)

Publication Number Publication Date
TW256773B true TW256773B (zh) 1995-09-11

Family

ID=10732358

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083102373A TW256773B (zh) 1993-03-19 1994-03-18

Country Status (15)

Country Link
EP (1) EP0689439B1 (zh)
JP (1) JPH08507782A (zh)
AP (1) AP478A (zh)
AT (1) ATE198831T1 (zh)
AU (1) AU6217694A (zh)
DE (1) DE69426622T2 (zh)
DK (1) DK0689439T3 (zh)
ES (1) ES2153854T3 (zh)
GB (1) GB9305693D0 (zh)
GR (1) GR3035528T3 (zh)
IL (1) IL109034A (zh)
PT (1) PT689439E (zh)
TW (1) TW256773B (zh)
WO (1) WO1994021260A1 (zh)
ZA (1) ZA941938B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9424766D0 (en) * 1994-12-07 1995-02-08 Wellcome Found Pharmaceutical composition
DE19603984A1 (de) * 1996-02-05 1997-08-07 Bayer Ag Granulate von Triazinen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU530999B2 (en) * 1979-06-01 1983-08-04 Wellcome Foundation Limited, The Substituted amino triazines and their use in treatment of cns disorders
GB8613183D0 (en) * 1986-05-30 1986-07-02 Wellcome Found Triazine salt
JP2632754B2 (ja) * 1991-05-21 1997-07-23 塩野義製薬株式会社 脳内グルタミン酸遊離抑制剤

Also Published As

Publication number Publication date
AP478A (en) 1996-03-08
AP9400627A0 (en) 1994-04-30
JPH08507782A (ja) 1996-08-20
WO1994021260A1 (en) 1994-09-29
EP0689439B1 (en) 2001-01-24
DE69426622D1 (de) 2001-03-01
ATE198831T1 (de) 2001-02-15
ES2153854T3 (es) 2001-03-16
GB9305693D0 (en) 1993-05-05
PT689439E (pt) 2001-05-31
IL109034A0 (en) 1994-06-24
EP0689439A1 (en) 1996-01-03
ZA941938B (en) 1995-09-18
GR3035528T3 (en) 2001-06-29
IL109034A (en) 1998-12-06
DE69426622T2 (de) 2001-06-21
DK0689439T3 (da) 2001-04-17
AU6217694A (en) 1994-10-11

Similar Documents

Publication Publication Date Title
TW249874B (zh)
DK76893D0 (zh)
TW256773B (zh)
IN184266B (zh)
IN178722B (zh)
ECSDI930095S (zh)
IN180031B (zh)
IN176120B (zh)
GB9314055D0 (zh)
ECSDI930129S (zh)
IN180774B (zh)
IN182841B (zh)
IN186823B (zh)
IN181559B (zh)
IN187355B (zh)
IN182850B (zh)
IN186801B (zh)
IN186399B (zh)
IN186151B (zh)
IN186074B (zh)
IN180818B (zh)
IN175100B (zh)
IN182685B (zh)
IN182464B (zh)
IN181236B (zh)